Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
低危患者新辅助内分泌治疗联合或不联合帕博西尼:一项 III 期随机双盲 SAFIA 试验
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-04588-3
Alsaleh, K; Al Zahwahry, H; Bounedjar, A; Oukkal, M; Saadeddine, A; Mahfouf, H; Bouzid, K; Bensalem, A; Filali, T; Abdel-Razeq, H; Larbaoui, B; Kandil, A; Abulkhair, O; Al Foheidi, M; Ghosn, M; Rasool, H; Boussen, H; Mezlini, A; Haddaoui, A; Ayari, J; Al Ghamdi, M; Errihani, H; Abdel-Aziz, N; Arafah, M; Dabouz, F; Bahadoor, M; Kullab, S; Nabholtz, J M